High cancer drug prices are a worsening trend in cancer care and are affecting patient care
and our health care system. In the United States, the average price of cancer drugs for about …

Tremendous progress in treatment and outcomes has been achieved across the whole
range of haematological malignancies in the past two decades. Although cure rates for …

Financial difficulties, measured by the EORTC C30 questionnaire, were associated with
worse quality of life and shorter overall survival of cancer patients enrolled in 16 academic …

Context Financial toxicity (FT) refers to the detrimental effects of financial strain caused by a
cancer diagnosis on the well-being of patients and their families. It is highly prevalent among …

Patients with cancer face an array of financial consequences as a result of their diagnosis
and treatment, collectively referred to as financial toxicity (FT). In the past 10 years, the body …

Financial barriers to clinical trial enrollment are an area of active investigation. Financial
toxicity as a concept describes how high costs and financial burden can lead to …

Purpose The burden of chronic obstructive pulmonary disease (COPD) is high in rural
America. Few studies, however, have examined urban/rural differences in health care …

Recent research supports the premise of studying social determinants of health in
conjunction with cancer survivorship (Hastert TA, 2021). It is widely appreciated that the …

We commend Dr. Zafar for continuing to highlight the critical issue of financial toxicity in
cancer care and the call to action for the development of interventions to minimize the …

Objectives: Patients with cancer can experience substantial financial burden. Little is known
about patients' preferences for incorporating cost discussions into treatment decision making …